Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (331-340 of 668) with videos related to

Pageof 67
Sort By:
Blood Transfusion = Trasfusione Del Sangue|May 14, 2016
High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of lifeSantiago García-López, Judith Millastre Bocos, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapyGema de la Poza, Antonio López-Sanroman, Carlos Taxonera, et al.
Journal of Clinical Gastroenterology|September 8, 2005
Comparison of gastric endoscopic lesions and tolerability to ibuprofen and ibuprofen-arginate in healthy subjectsJavier P Gisbert, Francisco Abad-Santos, Jesús Novalbos, et al.
Annals of Gastroenterology|January 6, 2022
Assessment of first-line eradication treatment in Greece: data from the European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg)Theodore Rokkas, Sotirios Georgopoulos, Spyros Michopoulos, et al.
Gastroenterologia Y Hepatologia|July 18, 2020
The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functionsYamile Zabana, Julián Panés, Pilar Nos, et al.
Annals of Hematology|January 23, 2009
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort studyJuan-Alfonso Soler, Mercé Güell, Meritxell Bricullé, et al.
Therapeutic Advances in Gastroenterology|July 2, 2016
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infectionIgnasi Puig, Sheila López-Góngora, Xavier Calvet, et al.
The Cochrane Database of Systematic Reviews|June 29, 2016
Sequential versus standard triple first-line therapy for Helicobacter pylori eradicationOlga P Nyssen, Adrian G McNicholl, Francis Megraud, et al.
Helicobacter|April 1, 2025
Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp-EuReg): Results of a Nationwide SurveyJavier Tejedor-Tejada, Samuel J Martínez-Domínguez, Luis Hernández, et al.
Expert Opinion on Biological Therapy|April 11, 2023
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)Bernd Bokemeyer, Tibor Hlavaty, Matthieu Allez, et al.
Pageof 67

Showing results (331-340 of 668) with videos related to

Sort By:
Pageof 67
Blood Transfusion = Trasfusione Del Sangue|May 14, 2016
High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of lifeSantiago García-López, Judith Millastre Bocos, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis|March 13, 2012
Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapyGema de la Poza, Antonio López-Sanroman, Carlos Taxonera, et al.
Journal of Clinical Gastroenterology|September 8, 2005
Comparison of gastric endoscopic lesions and tolerability to ibuprofen and ibuprofen-arginate in healthy subjectsJavier P Gisbert, Francisco Abad-Santos, Jesús Novalbos, et al.
Annals of Gastroenterology|January 6, 2022
Assessment of first-line eradication treatment in Greece: data from the European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg)Theodore Rokkas, Sotirios Georgopoulos, Spyros Michopoulos, et al.
Gastroenterologia Y Hepatologia|July 18, 2020
The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functionsYamile Zabana, Julián Panés, Pilar Nos, et al.
Annals of Hematology|January 23, 2009
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort studyJuan-Alfonso Soler, Mercé Güell, Meritxell Bricullé, et al.
Therapeutic Advances in Gastroenterology|July 2, 2016
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infectionIgnasi Puig, Sheila López-Góngora, Xavier Calvet, et al.
The Cochrane Database of Systematic Reviews|June 29, 2016
Sequential versus standard triple first-line therapy for Helicobacter pylori eradicationOlga P Nyssen, Adrian G McNicholl, Francis Megraud, et al.
Helicobacter|April 1, 2025
Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp-EuReg): Results of a Nationwide SurveyJavier Tejedor-Tejada, Samuel J Martínez-Domínguez, Luis Hernández, et al.
Expert Opinion on Biological Therapy|April 11, 2023
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)Bernd Bokemeyer, Tibor Hlavaty, Matthieu Allez, et al.
Pageof 67